| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817962 | Clinical Biochemistry | 2013 | 5 Pages |
Abstract
sE-cadherin may be a marker predicting response to PST for patients with breast cancer. Our findings warrant further evaluation of sE-cadherin in a prospective trial.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
G. Hofmann, M. Balic, N. Dandachi, M. Resel, W. Schippinger, P. Regitnig, H. Samonigg, T. Bauernhofer,